| |
|
|
|
|
|
 |
| |
|
½ºÅäÁüݼ¿ STOZIME CAP[Aminophylline , Dextromethorphan HBr , Lysozyme chloride]
|
|
Àü¹®ÀǾàǰ | ºñ±Þ¿©
|
|
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
|
|
|
 | Çã°¡Á¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇÑ±Ý¾× |
ºñ±Þ¿©
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
|
| ºü¸¥Á¶È¸ |
|
| Á¦Ç°¼º»ó |
¹é»öºÐ¸»ÀÌ ÃæÁøµÈ »óºÎ ³ì»ö, ÇϺΠ¿¬³ì»öÀÇ °æÁúݼ¿Á¦
[Á¦ÇüÁ¤º¸ È®ÀÎ] |
| È¿´ÉÈ¿°ú |
[ÀûÀÀÁõ º° °Ë»ö]
±âħ, °¡·¡
[Drugbank ÀÇ ¼ººÐÁ¤º¸¿¶÷] [Aminophylline][Dextromethorphan]
|
| ¿ë¹ý¿ë·® |
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
¼ºÀÎ 1ȸ 1ݼ¿ 1ÀÏ 2ȸ(¾ÆÄ§, Àú³á) º¹¿ëÇÑ´Ù.
|
| ½ÅÁßÅõ¿© |
- º»ÀÎ ¶Ç´Â ¾çÄ£, ÇüÁ¦ µîÀÌ µÎµå·¯±â, Á¢Ã˼º ÇǺο°, ¾Ë·¹¸£±â¼º ºñ¿°, ÆíµÎÅë, À½½Ä¹° ¾Ë·¹¸£±â µîÀ» ÀÏÀ¸Å°±â ½¬¿î üÁúÀ» °®°í ÀÖ´Â »ç¶÷
- ¾àÀ̳ª ´Þ°¿¿¡ ÀÇÇØ ¾Ë·¹¸£±â Áõ»óÀ» ÀÏÀ¸Å² ÀÏÀÌ Àִ ȯÀÚ
- °£Àå¾Ö, ½ÅÀå¾Ö, °©»ó¼±Áúȯ, ´ç´¢º´ µî º´ÀÌ Àִ ȯÀÚ. °í¿È¯ÀÚ, Çã¾àÀÚ
- °£Àå¾Ö ¹× °íÇ÷¾Ð ȯÀÚ, °í·ÉÀÚ
- ÀӺΠ¶Ç´Â ÀÓ½ÅÇϰí ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ºÎÀÎ, ¼öÀ¯ºÎ
- ´Ù¸¥ ¾à¹°À» Åõ¿©¹Þ°í Àִ ȯÀÚ
|
| ÀÌ»ó¹ÝÀÀ |
ÀÌ ¾àÀ» Åõ¿©ÇÏ´Â µ¿¾È ¹ßÁø, ¹ßÀû, ±¸¿ª, ±¸Åä, ½Ä¿åºÎÁø, ¾îÁö·¯¿ò µîÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â Åõ¿©¸¦ ÁßÁöÇÏ°í ¾à»ç ¶Ç´Â ÀÇ»ç¿Í »óÀÇÇÑ´Ù.
|
| »óÈ£ÀÛ¿ë |
´ÙÀ½ ¾àµé°ú º´¿ëÅõ¿©ÇÏÁö ¾Ê´Â´Ù.
- ´Ù¸¥ ÁøÇذŴãÁ¦, °¨±â¾à, Ç×È÷½ºÅ¸¹ÎÁ¦, ÁøÁ¤Á¦, ¾ËÄÚ¿Ã µî |
| Off-label Usage |
[Á¶È¸]
|
| Related FDA Approved Drug |
|
|
|
 | Á¤º¸¿ä¾à |
|
|
|
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
|
|
 | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |
|
|
| |
|
 | Á¦Ç°Á¤º¸ |
|
|
|
|
 | º¹¾àÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| LACTmed ¹Ù·Î°¡±â |
[¹Ù·Î°¡±â]
|
| ¾à¸®ÀÛ¿ë |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| Pharmacokinetics |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ |
[º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
|
| º¹¾à¶óº§ |
| À̹ÌÁö |
º¹¾à¼³¸í |
 |
¾îÁö·¯¿òÀÌ ÀÖÀ»¼ö ÀÖ½À´Ï´Ù. |
|
|
| * |
º¹¾àÀ̹ÌÁö´Â ¸ðµç º¹¾àÁöµµ »çÇ×À» Ç¥½ÃÇѰÍÀº ¾Æ´Ï¸ç, Ãß°¡ÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ°Å³ª ¼öÁ¤µÉ ¼ö ÀÖ½À´Ï´Ù. |
| * |
º¹¾àÀ̹ÌÁöÀÇ Ç¥½Ã¿©ºÎ´Â ½ÇÁ¦ ¾à¹°º¹¿ë½Ã Á߿䵵¿¡ µû¸¥°ÍÀº ¾Æ´Ï¸ç ´Ü¼øÈ÷ Çã°¡Á¤º¸»ó Ű¿öµå¸¦ ±âÁØÀ¸·Î µî·ÏµÇ¾ú½À´Ï´Ù. |
| * |
±ÍÇϰ¡ º¹¾àÀ̹ÌÁö Á¤º¸¸¦ ½Å·ÚÇÔÀº ÀüÀûÀ¸·Î ±ÍÇÏÀÇ Ã¥ÀÓÀÔ´Ï´Ù. µå·°ÀÎÆ÷´Â ÀÌ¿¡ ´ëÇÑ ¾î¶°ÇÑ º¸Áõµµ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
| º¸°ü»ó ÁÖÀÇ |
|
| Á¶Á¦½Ã ÁÖÀÇ |
|
|
|
 | ½É»çÁ¤º¸ |
|
|
|
|
 | ÇмúÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| DUR (ÀǾàǰ»ç¿ëÆò°¡) |
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
|
| µ¶¼ºÁ¤º¸ |
Dextromethorphan¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Lysozyme¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do |
| Mechanism of Action |
Aminophylline¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Theophylline is structurally related to theobromine and caffeine. The precise mechanism of action of theophylline is not known.
Dextromethorphan¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Dextromethorphan is an opioid-like drug that binds to and acts as antagonist to the NMDA glutamatergic receptor, it is an agonist to the opioid sigma 1 and sigma 2 receptors, it is also an alpha3/beta4 nicotinic receptor antagonist and targets the serotonin reuptake pump. Dextromethorphan is rapidly absorbed from the gastrointestinal tract, where it enters the bloodstream and crosses the blood-brain barrier. The first-pass through the hepatic portal vein results in some of the drug being metabolized into an active metabolite of dextromethorphan, dextrorphan, the 3-hydroxy derivative of dextromethorphan.
|
| Pharmacology |
Aminophylline¿¡ ´ëÇÑ Pharmacology Á¤º¸ Aminophylline is the ethylenediamine salt of theophylline. Theophylline stimulates the CNS, skeletal muscles, and cardiac muscle. It relaxes certain smooth muscles in the bronchi, produces diuresis, and causes an increase in gastric secretion.
Dextromethorphan¿¡ ´ëÇÑ Pharmacology Á¤º¸ Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
|
| Metabolism |
Aminophylline¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Not Available
Dextromethorphan¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 2D6 (CYP2D6)
|
| Protein Binding |
Aminophylline¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ 60%
|
| Half-life |
Aminophylline¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ 7-9 hours
Dextromethorphan¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ 3-6 hours
|
| Absorption |
Aminophylline¿¡ ´ëÇÑ Absorption Á¤º¸ Not Available
Dextromethorphan¿¡ ´ëÇÑ Absorption Á¤º¸ Rapidly absorbed from the gastrointestinal tract.
|
| Pharmacokinetics |
AminophyllineÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
1.ºÐÆ÷ Vd = 0.45L/kg
2.¸ðÀ¯·Î °ÅÀÇ Ç÷Áß³óµµ¿Í °°Àº Á¤µµ·Î ºÐÆ÷Çϸç Źݵµ Åë°ú
3.´ë»ç : °£¿¡¼ demethylation, oxidation
4.¹Ý°¨±â : ³ªÀÌ, °£ ±â´É, ½É ±â´É, Æó Áúȯ, Èí¿¬·Â¿¡ µû¶ó ¸Å¿ì ´Ù¾ç
¡á AminophyllineÀÇ ¹Ý°¨±â
|
ȯÀÚ±º |
¹Ý°¨±â(hr) |
|
½Å»ý¾Æ |
|
|
¹Ì¼÷¾Æ |
30 |
|
Á¤»óºÐ¸¸ |
24 |
|
¿µ¾Æ |
|
|
4-52ÁÖ |
4-30 |
|
¼Ò¾Æ/û¼Ò³â |
|
|
1-9¼¼ |
2-10 (Æò±Õ4) |
|
9-16¼¼ |
4-16 |
|
¼ºÀÎ |
|
|
ºñÈí¿¬ÀÚ |
|
|
Èí¿¬ÀÚ |
4.4 |
|
½ÉÁúȯ,°£ºÎÀü |
20-30 |
¡á AminophyllineÀÇ ¿ªµ¿ÇÐ/¾à·ÂÇÐ
|
Á¦Çü |
ÃÖ°íÇ÷Áß³óµµ µµ´Þ½Ã°£ |
Åõ¿© °£°Ý |
|
³ªÁ¤/½Ã·´ |
2½Ã°£ |
6½Ã°£ |
|
Àå¿ëÁ¤ |
5½Ã°£ |
12½Ã°£ |
|
ÃòÀ×Á¤ |
1-1.5½Ã°£ |
6½Ã°£ |
|
¼¹æÁ¤ |
4-7½Ã°£ |
12½Ã°£ |
|
ÁÖ»çÁ¦ |
30ºÐÀÌÇÏ |
|
5.¼Ò½Ç : ¼Òº¯
6.¼ºÀÎÀº 10%°¡ ¹Ìº¯Èü·Î ¹è¼³µÇ°í ½Å»ý¾Æ´Â ´õ ¸¹Àº ¾ç(50%±îÁö)ÀÌ ¹Ìº¯Èü·Î ½Å¹è¼³µÈ´Ù.
Dextromethorphan HBrÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- ÁøÇØÀÛ¿ë ¹ßÇö½Ã°£ : 15~30ºÐ À̳»
- ÀÛ¿ëÁö¼Ó½Ã°£ : 6½Ã°£±îÁö
- ´ë»ç : °£´ë»ç
- ¼Ò½Ç : ÁÖ·Î ½Å¹è¼³
|
| Biotransformation |
Aminophylline¿¡ ´ëÇÑ Biotransformation Á¤º¸ Not Available
Dextromethorphan¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic. Rapidly and extensively metabolized to dextrorphan (active metabolite). One well known metabolic catalyst involved is a specific cytochrome P450 enzyme known as 2D6, or CYP2D6.
|
| Toxicity |
Aminophylline¿¡ ´ëÇÑ Toxicity Á¤º¸ Not Available
Dextromethorphan¿¡ ´ëÇÑ Toxicity Á¤º¸ Not Available
|
| Drug Interactions |
Aminophylline¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Aciclovir Acyclovir increases the effect and toxicity of theophyllineAdenosine This xanthine decreases the effect of adenosineButabarbital The barbiturate decreases the effect of theophyllineButalbital The barbiturate decreases the effect of theophyllineDihydroquinidine barbiturate The barbiturate decreases the effect of theophyllineAtracurium Theophylline decreases the effect of muscle relaxantCarbamazepine Carbamazepine increases or decreases the effect of theophyllineCarteolol Antagonism of action and increased effect of theophyllineCimetidine Cimetidine increases the effect of theophyllineCiprofloxacin The quinolone increases the effect of theophyllineClarithromycin Clarithromycin increases the effect amd toxicity of theophyllineDisulfiram Disulfiram increases the effect and toxicity of theophyllineDoxacurium Theophylline decreases the effect of muscle relaxantEnoxacin The quinolone increases the effect of theophyllineErythromycin The macrolide increases the effect and toxicity of theophyllineEthinyl Estradiol The contraceptive increases the effect and toxicity of theophyllineEthotoin Decreased effect of both productsFluvoxamine Fluvoxamine increases the effect and toxicity of theophyllineFosphenytoin Decreased effect of both productsGallamine Triethiodide Theophylline decreases the effect of muscle relaxantGrepafloxacin The quinolone increases the effect of theophyllineHalothane Increased risk of cardiac arrhythmiaInterferon Alfa-2a, Recombinant Interferon increases the effect and toxicity of theophyllineInterferon Alfa-2b, Recombinant Interferon increases the effect and toxicity of theophyllineInterferon alfa-n1 Interferon increases the effect and toxicity of theophyllineIsoniazid Isoniazid increases the effect and toxicity of theophhyllineJosamycin The macrolide increases the effect and toxicity of theophyllineMephenytoin Decreased effect of both productsMethohexital The barbiturate decreases the effect of theophyllineMetocurine Theophylline decreases the effect of muscle relaxantMexiletine Mexiletine increases the effect and toxicity of theophyllineMivacurium Theophylline decreases the effect of muscle relaxantNadolol Antagonism of action and increased effect of theophyllineNorfloxacin The quinolone increases the effect of theophyllinePancuronium Theophylline decreases the effect of muscle relaxantPefloxacin The quinolone increases the effect of theophyllinePeginterferon alfa-2a Interferon increases the effect and toxicity of theophyllinePeginterferon alfa-2b Interferon increases the effect and toxicity of theophyllinePentobarbital The barbiturate decreases the effect of theophyllinePentoxifylline Pentoxyfylline increases the effect and toxicity of theophyllinePhenytoin Decreased effect of both productsPindolol Antagonism of action and increased effect of theophyllinePrimidone The barbiturate decreases the effect of theophyllinePropafenone Propafenone increases the effect of theophyllinePropranolol Antagonism of action and increased effect of theophyllineQuinidine barbiturate The barbiturate decreases the effect of theophyllineRifampin Rifampin decreases the effect of theophyllineRitonavir Ritonavir decreases the effect of theophyllineRofecoxib Rofecoxib increases the effect and toxicity of theophyllineSecobarbital The barbiturate decreases the effect of theophyllineSotalol Antagonism of action and increased effect of theophyllineSt. John's Wort St. John's Wort decreases the effect of theophyllineTacrine Tacrine increases the effect and toxicity of theophyllineTalbutal The barbiturate decreases the effect of theophyllineTerbinafine Terbinafine increases the effect and toxicity of theophyllineThiabendazole Thiabendazole increases the effect and toxicity of theophyllineTiclopidine Ticlopidine increases the effect and toxicity of theophyllineTimolol Antagonism of action and increased effect of theophyllineTubocurarine Theophylline decreases the effect of muscle relaxantVecuronium Theophylline decreases the effect of muscle relaxantZileuton Zileuton increases the effect and toxicity of theophyllineVerapamil Verapamil increases the effect of theophyllineAmobarbital The barbiturate decreases the effect of theophyllineAprobarbital The barbiturate decreases the effect of theophyllineButethal The barbiturate decreases the effect of theophyllineHeptabarbital The barbiturate decreases the effect of theophyllineHexobarbital The barbiturate decreases the effect of theophyllineLithium Theophylline decreases serum levels of lithiumMestranol The contraceptive increases the effect and toxicity of theophyllineMethylphenobarbital The barbiturate decreases the effect of theophyllinePenbutolol Antagonism of action and increased effect of theophyllinePhenobarbital The barbiturate decreases the effect of theophyllineTroleandomycin The macrolide increases the effect and toxicity of theophylline
Dextromethorphan¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Dihydroquinidine barbiturate Quinidine increases the toxicity of dextromethorphanQuinidine Quinidine increases the toxicity of dextromethorphanQuinidine barbiturate Quinidine increases the toxicity of dextromethorphanFluoxetine Combination associated with possible serotoninergic syndromeIsocarboxazid Possible severe adverse reactionMemantine Increased risk of CNS adverse effectsMoclobemide Increased CNS toxicityParoxetine Combination associated with possible serotoninergic syndromePhenelzine Possible severe adverse reactionRasagiline Possible severe adverse reactionSelegiline Combination associated with possible serotoninergic syndromeSibutramine Combination associated with possible serotoninergic syndromeTerbinafine Terbinafine increases dextromethorphan levelsTranylcypromine Possible severe adverse reaction
|
CYP450 Drug Interaction |
[CYP450 TableÁ÷Á¢Á¶È¸] Dextromethorphan¿¡ ´ëÇÑ P450 table
SUBSTRATES
CYP 2D6
Beta Blockers:
S-metoprolol
propafenone
timolol
Antidepressants:
amitriptyline
clomipramine
desipramine
imipramine
paroxetine
Antipsychotics:
haloperidol
risperidone
thioridazine
aripiprazole
codeine
**dextromethorphan**
duloxetine
flecainide
mexiletine
ondansetron
tamoxifen
tramadol
venlafaxine
INHIBITORS
CYP 2D6
amiodarone
buproprion
chlorpheniramine
cimetidine
clomipramine
duloxetine
fluoxetine
haloperidol
methadone
mibefradil
paroxetine
quinidine
ritonavir
INDUCERS
CYP 2D6
N/A
|
| Food Interaction |
Aminophylline¿¡ ´ëÇÑ Food Interaction Á¤º¸ Take with food.Limit caffeine intake.Vitamin B6 needs increased, supplement recommended.
|
| Drug Target |
[Drug Target]
|
| SNP Á¤º¸ |
Name:Dextromethorphan (DB00514)
Interacting Gene/Enzyme:Cytochrome P450 2D6 (Gene symbol = CYP2D6) Swissprot P10635
SNP(s):CYP2D6*6 rs5030655 (T deletion, homozygote)
Effect:Poor drug metabolizer, lower dose requirements
Reference(s):Bradford LD, Gaedigk A, Leeder JS: High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data. Psychopharmacol Bull. 1998;34(4):797-804. [PubMed]
|
| Description |
Aminophylline¿¡ ´ëÇÑ Description Á¤º¸ Aminophylline is a drug combination that contains theophylline and ethylenediamine in 2:1 ratio. [Wikipedia]
Dextromethorphan¿¡ ´ëÇÑ Description Á¤º¸ The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity. [PubChem]
|
| Dosage Form |
Aminophylline¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Solution IntravenousTablet OralTablet, extended release Oral
Dextromethorphan¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Capsule OralLiquid OralLozenge OralStrip OralSuspension OralSyrup OralTablet Oral
|
| Drug Category |
Aminophylline¿¡ ´ëÇÑ Drug_Category Á¤º¸ Bronchodilator AgentsCardiotonic AgentsPhosphodiesterase InhibitorsRespiratory Smooth Muscle Relaxants
Dextromethorphan¿¡ ´ëÇÑ Drug_Category Á¤º¸ Analgesics, OpioidAntitussive AgentsExcitatory Amino Acid Antagonists
|
| Smiles String Canonical |
Aminophylline¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ NCCN.CN1C(=O)N(C)C2=C(NC=N2)C1=O.CN1C(=O)N(C)C2=C(NC=N2)C1=O
Dextromethorphan¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ COC1=CC2=C(CC3C4CCCCC24CCN3C)C=C1
|
| Smiles String Isomeric |
Aminophylline¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ NCCN.CN1C(=O)N(C)C2=C(NC=N2)C1=O.CN1C(=O)N(C)C2=C(NC=N2)C1=O
Dextromethorphan¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
|
| InChI Identifier |
Aminophylline¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2/f/h2*8H;
Dextromethorphan¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18-/m1/s1
|
| Chemical IUPAC Name |
Aminophylline¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 1,3-dimethyl-7H-purine-2,6-dione; 1,3-dimethyl-7H-purine-2,6-dione; ethane-1,2-diamine
Dextromethorphan¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ Not Available
|
|
|
 | »ç¿ëÀÚÄÁÅÙÃ÷ |
|
|
|
|
|
-
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2015-02-04
-
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
|
|
¾Ë¸² |
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù. |
|
°æ°í |
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
|
|
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
|
|
|
|